Targeting EZH2 to treat ETP-ALLFebruary 19, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Risk of reproductive problems in male cancer survivorsFebruary 19, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Pinpointing the cells that cause CML relapseFebruary 18, 2016Leukemia, Myelodysplasia, TransplantationCML
Drug shows promise for treating resistant AML, MCLFebruary 17, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin Lymphoma
Gene variants linked to drug intoleranceFebruary 16, 2016Leukemia, Myelodysplasia, TransplantationALL
Chemo linked to long-term learning problems in ALL survivorsFebruary 12, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
New insight into Ph-like ALL could lead to new treatmentFebruary 9, 2016Leukemia, Myelodysplasia, TransplantationALL
Induction ALL treatment can cause bone lossFebruary 7, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
New assay detects persistent CML better, team saysFebruary 5, 2016Leukemia, Myelodysplasia, TransplantationCML
FDA approves drug for patients receiving MECFebruary 5, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Generic imatinib launched with savings programFebruary 4, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPediatricsPharmacyALLMyelodysplastic Syndrome
Olfactory receptor could be target for AML therapyFebruary 3, 2016Leukemia, Myelodysplasia, TransplantationAML
EHA creates ‘roadmap’ for hematology researchFebruary 3, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaThrombosisBlood Banking
When loved ones get cancer, people turn to the WebFebruary 2, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues